Kinase Inhibitors

QL-X-138 HCl View larger

QL-X-138 HCl

AT38960L

Molarity Calculation Cart®

HOW TO ORDER

$166.00

$166.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $74.70 Total: $7,470.00
150 $86.32 Total: $4,316.00
125 $101.26 Total: $2,531.50
110 $119.52 Total: $1,195.20
15 $141.10 Total: $705.50

Data sheet

Molecular FormulaC25H20ClN5O2
Molecular Weight457.91
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeO=C(NC1=CC(N2C(C=CC3=CN=C4C=CC(C5=CNN=C5)=CC4=C32)=O)=CC=C1C)C=C.Cl[H]
ReferencesWu H, et al. Discovery of a BTKMNK dual inhibitor for lymphoma and leukemia. Leukemia. 2016 Jan;30[1] 173-81.

More info

QL-X-138 HCl is a novel selective and highly potent BTKMNK dual-kinase inhibitor with anticancer activity that binds covalently to BTK and noncovalently to MNK. QL-X-138 HCl inhibited BTK, MNK1, and MNK2 kinases. QL-X-138 HCl has anti-dengue virus 2 activity and shows anti-proliferative activity in acute myeloid leukemia cells. QL-X-138 HCl can be used to study lymphoma and leukemia.